gip/glp 1-agonist tirzepatide Targeting GLP-1, GIP & GCG in Obesity and Type 2 Diabetes Research TrimRX | GLP-1 vs GIP:
Description
Double layer spherical nanoparticles with hyaluronic acid coating to enhance oral delivery of exenatide in T2DM rats
Blacher, E
This is especially relevant for patients also taking insulin or sulfonylureas, who should monitor for hypoglycemia symptoms
Real care
Gastrointestinal side effects are the most common adverse reactions, particularly during dose escalation
This medication helps to improve blood sugar control by stimulating insulin production and reducing glucose in the liver
